Humacyte
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $10,790 |
Gross Profit | -1,823 | -1,791 | 7,412 |
EBITDA | -52,325 | -28,289 | -20,001 |
EBIT | -54,148 | -30,080 | -23,379 |
Net Income | -56,663 | -31,896 | -25,106 |
Net Change In Cash | 0 | 0 | 10,790 |
Free Cash Flow | -21,475 | -27,738 | -19,204 |
Cash | 93,563 | 115,505 | 80,592 |
Basic Shares | 119,174 | 108,246 | 103,607 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $1,565 | $1,263 | $1,491 |
Gross Profit | -76,550 | -6,690 | 1,214 | -6,941 |
EBITDA | -96,458 | 2,490 | -72,967 | -56,249 |
EBIT | -104,177 | -5,765 | -81,249 | -64,681 |
Net Income | -110,776 | 64,219 | 37,536 | -68,726 |
Net Change In Cash | 0 | 1,565 | 1,263 | 1,491 |
Free Cash Flow | -75,585 | -72,177 | -81,410 | -55,886 |
Cash | 80,448 | 149,772 | 217,502 | 39,929 |
Basic Shares | 103,420 | 103,051 | 39,970 | 12,449 |
Earnings Calls
| Quarter | EPS |
|---|---|
2021-06-30 | -$0.71 |
2021-03-31 | -$0.75 |
2020-12-31 | -$0.90 |
2020-06-30 | -$3.06 |
